1 / 18

SHIVERS Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

SHIVERS Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance. Nikki Turner March 2012. http:// www.grabonestore.co.nz/man-flu-joke-set?utm_source=GrabOne+Store+New+Zealand&utm_campaign=ET_18393_nz-store_new-zealand_20120321&utm_medium=email

heidi
Télécharger la présentation

SHIVERS Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SHIVERSSouthern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance Nikki Turner March 2012

  2. http://www.grabonestore.co.nz/man-flu-joke-set?utm_source=GrabOne+Store+New+Zealand&utm_campaign=ET_18393_nz-store_new-zealand_20120321&utm_medium=emailhttp://www.grabonestore.co.nz/man-flu-joke-set?utm_source=GrabOne+Store+New+Zealand&utm_campaign=ET_18393_nz-store_new-zealand_20120321&utm_medium=email http://www.vaccineinfo.net/immunization/vaccine/influenza/index.shtml http://fnp2011.wordpress.com/2011/03/04/having-influenza/ http://www.briancombs.net/tag/swine-flu/

  3. I have flu doctor……. • How do we recognise flu • How much is really • in the community • In hospital presentations • What are its characteristic presentations • Are we diagnosing it all • Is there subclinical/asymptomatic? • How effective are current flu vaccines • In subpopulations • In different years with shifting strains http://www.extension.org/pages/24425/avian-influenza-homepage

  4. Influenza and other respiratory diseases in southern hemisphere • CDC Announcement: 27 Dec 2010 • Application Due date: 14 Mar 2011 • Research for 9 objectives: • Two primary objectives • Seven additional objectives • Study period: • 1st year: Two primary objectives • 2nd – 5th years: Two primary objectives + additional objectives • Notice of award: Oct 2011

  5. CDCs 9 objectives • Understand severe respiratory diseases caused by influenza & other pathogens • Assess influenza vaccine effectiveness • Investigate interaction between influenza & other pathogens • Understand causes of respiratory mortality • Understand non-severe respiratory diseases caused by influenza & other pathogens • Estimate influenza infection by conducting serosurvey • Identify & quantify risk factors (age, ethnicity, SES etc) for getting influenza • Assess immune response among individuals with varying disease spectrum • Estimate healthcare, societal economic burden caused by influenza and vaccine cost-effectiveness

  6. Project Team – multi-centre and multi-disciplinary collaboration • ESR—leading organization • Sue Huang—Principle investigator (PI) • Graham Mackereth – Project manager • Ruth Seeds – Project Officer • Science teams: • Sue Huang/Sally Roberts/Colin McArthur/Cameron Grant/Debbie Williamson/Adrian Trenholme/Conroy Wong/Susan Taylor/Graham Mackereth/Don Bandaranayake/Diane Gross/Marc-Alain Widdowson: objective 1 • Nikki Turner/Heath Kelly/Nevil Pierse/Ange Bissielo/Michael Baker/Don Bandaranayake/Sue Huang: objective 2 Vaccine Effectiveness • Michael Baker: objectives 3 & 7 • Colin McArthur/Sally Roberts: objective 4 • Sue Huang/Nikki Turner: objective 5 Primary Care Surveillance • Sue Huang/Don Bandaranayake: objective 6 • Richard Webby: objective 8 • Des O’Dea: objective 9

  7. Tools: Two surveillance systems • Hospital-based surveillance: enhanced, active, year-round (5 yrs), population based surveillance for hospital SARI (sudden acute respiratory) cases • Auckland and Middlemore Hospitals • Community-based surveillance: enhanced, active, (4 yrs), population based surveillance for community ILI (Influenza-like illness) cases caused by influenza • Recruitment of 50 – 100 ‘sentinel’ General Practices in greater Auckland (200,000 – 400,000 patients)

  8. Objective 1 – Hospital-based surveillance • Identify the aetiology of hospitalised severe acute respiratory infections, including influenza • Describe possible risk factors eg asthma high BMI, pregnancy etc • Will need to access some practice data ?PMS extraction • Flu vccinationhx • High risk medical conditions • Medication lists • Pneumococcal vaccination hx • Utilise this data for VE measures

  9. Objective 5 – Community-based surveillanceSue Huang and Nikki TurnerSHIVERS Researchers • Identify the aetiologies of acute presentations to the general practice with respiratory symptoms, including influenza • Cough • Fever • Describe possible risk factors eg asthma high BMI, chronic conditions,pregnancy, ethnicity, age, ses • Utilise this data for VE measures

  10. Needs….. • Sentinel GP surveillance starting in 2013 • 60 GPs: ~ 180,000 registered patients (14% Auckland population) • ?All year round • All acute respiratory illnesses presenting if possible: • Swab • Questionnaire (brief, advanced form) • PMS data extraction

  11. Gains for General Practice • Improved understanding of causes of respiratory illnesses • Rapid feedback of swab results to the involved practices • flu • Anther virus • Information on spread of flu in the community in real time • Yearly Vaccine Effectiveness measures • If numbers large enough, in subpopulations • Better understanding of symptomatic presentation of flu/nonflu • Hope to build into a Cornerstone indicator/ MOPS • Showcase NZ General practice to the world • Enrolled populations • Excellent systems • Ability to utlilise PMS data/data extraction

  12. Thank you

  13. Data requirement (PMS) • Influenza vaccination record: this year and previous years; type and date; batch number • Pneumococcal vaccination record: type of vaccine, date • Read codes: high risk medical conditions. • Read codes: current, ex or non-smoker • Read codes: last recorded BMI or body weight • Medication list: identify medications associated with chronic disease (asthma, heart disease, COPD, cancer, immunosuppression) • Outbox: count all hospital admissions, ED visits, A&M visits in the past 12 months • Count number of GP and practice nurse visits in the past 12 months • Any prescription issued for antivirals in the past 12 months (Tamiflu or Relenza)

  14. Data requirement (Questionnaire) • Clinical symptoms and history of current illness • Additional risk factor information • Treatment • Disease course • Employment condition • Living condition • BMI (if not available on PMS) • Pregnancy

  15. Laboratory testing

  16. Objective 6 – Serosurvey for seasonal influenza infection Don Bandaranayake, Sue Huang

  17. Specific aims • estimate the annual incidence of infection with seasonal influenza in the Auckland region. • To collect information on host, environmental, behavioral factors and health service utilization. • To estimate the disease burden of all seasonal influenza infections [from asymptomatic, mild and severe infections to deaths].

  18. Some ILI patients (Blood) Strat. random sample Some SARI patients’ blood All SARI patients (respiratory specimen) All ILI patients (respiratory specimen) • 6 • Infection risk • 8 • Immune response Cases + subcohort • 3 • Interactions • 5 • Mild disease Cases + controls 1 Severe disease Cases + controls • 2 • VE • 4 • Mortality Cases + controls Cases + controls • 7 • Risk factor impact Specimen flow • 9 • Economics Data flow

More Related